Thursday 14 January
Innate immunity in the pathophysiology of autoinflammatory diseases
- KD pathogenic insights and novel therapeutic targets from experimental murine models
Moshe Arditi (USA)
- Is KD an IgA vasculitis?
Magali Noval Rivas (USA)
- From immunobiology to classification – lessons learned from KD
Rae Yeung (Canada)
- Can biomarkers support treatment decisions in KD?
Dirk Foell (Germany)